跨境传染病科普框架构建

李洁; 庞明樊; 武洁雯; 房元圣; 杨昕娉; 纪瀚然; 徐健; 戚晓鹏

doi:10.3784/jbjc.202302070029

跨境传染病科普框架构建

doi: 10.3784/jbjc.202302070029

1.
中国疾病预防控制中心全球公共卫生中心, 北京 102206
2.
中国再保险（集团）股份有限公司, 北京 100033

基金项目: “一带一路”公共卫生合作项目（No. 0534）

详细信息

作者简介:
李洁，女，安徽省滁州市人，在读硕士，主要从事全球公共卫生研究工作，Email：li_jie97 @163.com

通讯作者:
戚晓鹏，Tel：010−58900327，Email：qixp@chinacdc.cn

中图分类号: R211; R51
计量
- 文章访问数: 94
- HTML全文浏览量: 46
- PDF下载量: 10
- 被引次数: 0
出版历程
- 收稿日期: 2023-02-07
- 网络出版日期: 2023-05-05

Cross-border infectious disease science framework construction

1.
Center for Global Public Health, Chinese Center for Disease Control and Prevention, Beijing 102206, China
2.
China Reinsurance (Group) Corporation, Beijing 102206, China

Funds: This study was supported by the “One Belt One Road” Public Health Cooperation Project (No. 0534)

More Information

Corresponding author: Qi Xiaopeng, Email: qixp@chinacdc.cn

摘要

摘要: 目的构建跨境传染病科普框架，为跨境传染病科普工作者提供理论性参考和整体解决方案，完善科普工作，提高出境人员传染病知识素养，降低传染病跨境传播和输入风险。方法使用框架构建法，通过范围界定、资料查找和分析、需求分析及利益相关者分析法迭代构建跨境传染病科普框架，并通过讨论验证最终确定框架。结果框架以跨境人员传染病科普需求为中心，通过建立全球传染病监测体系，构建基于证据的传染病知识库，选择适宜的科普材料制作与传播，运用恰当的科普评价方法，建立成熟的科普部门体系来满足需求。结论跨境传染病科普框架的建立将为该领域的科普实施提供指导，为相关部门的通力合作提供依据，为跨境传染病防控提供支撑。
- 跨境传染病 /
- 科普 /
- 框架
Abstract: Objective To construct framework for the popularization of science on cross-border infectious diseases (CBID), providing theoretical reference and total solutions for CBID science practitioners, improving their work, lifting infectious diseases knowledge literacy among Cross-borderers, minimizing cross-border transmission and importation risk. Methods The framework construction method: Scoping, data search and analysis, using needs analysis and stakeholder mapping development first draft, discussion and validation then finalize framework. Results The framework centered on the needs of CBID science popularization, and meets the demand by establishing a global infectious disease surveillance system, evidence-based infectious disease knowledge base, appropriate mechanisms for the generation and dissemination of science materials, applying appropriate science popularization. Conclusion The establishment of this framework will provide guidance for the implementation in this field, provide a basis for the full cooperation of relevant departments, and provide support for the prevention and control of cross-border infectious diseases.
- Cross-border infectious diseases /
- Science popularization /
- Framework

HTML全文

图 1 跨境传染病科普框架构建步骤

Figure 1. Process of constructing a framework for the popularization of cross-border infectious diseases

下载: 全尺寸图片幻灯片

图 2 跨境传染病科普框架整体架构

Figure 2. Overall structure of the Cross-border Infectious Disease Science Framework

下载: 全尺寸图片幻灯片

图 3 跨境人员传染病科普需求分析

Figure 3. Cross-borders infectious disease popularization needs analysis

下载: 全尺寸图片幻灯片

图 4 跨境传染病科普利益相关者分析

Figure 4. Stakeholder analysis of infectious disease popularization

下载: 全尺寸图片幻灯片

参考文献(21)

[1]	World Tourism Organization. Global and regional tourism performance[EB/OL]. (2019-12-31)[2022-10-27]. https://www.unwto.org/tourism-data/global-and-regional-tourism-performance.
[2]	国家统计局. 国内居民出境人数(万人次)[EB/OL]. (2021-10-31)[2022-10-21]. https://data.stats.gov.cn/easyquery.htm?cn=C01&zb=A0K01&sj=2021. National Bureau of Statistics. Number of domestic residents leaving the country (million)[EB/OL]. [2022-10-21]. https://data.stats.gov.cn/easyquery.htm?cn=C01&zb=A0K01&sj=2021.
[3]	Steffen R. Epidemiology: morbidity and mortality in travelers[M]//Keystone JS, Kozarsky RE, Freedman DO, et al. Travel Medicine. 2^nd ed. Amsterdam: Elsevier, 2008: 5−11. DOI: 10.1016/B978-0-323-03453-1.10002-1.
[4]	Sridhar S, Régner I, Brouqui P, et al. Methodologies for measuring travelers' risk perception of infectious diseases: a systematic review[J]. Travel Med Infect Dis, 2016, 14(4): 360–372. DOI: 10.1016/j.tmaid.2016.05.012.
[5]	张朓, 龙江, 黄青徽, 等. 重庆口岸出境劳务人员艾滋病预防性干预措施研究[J]. 中国国境卫生检疫杂志,2021,44(4):268–271,279. DOI:10.16408/j.1004−9770.2021.04.010. Zhang T, Long J, Huang QH, et al. Study of intervention measures for AIDS among outbound workers at Chongqing Port[J]. Chin J Front Health Quar, 2021, 44(4): 268–271,279. DOI: 10.16408/j.1004−9770.2021.04.010.
[6]	Kain D, Findlater A, Lightfoot D, et al. Factors affecting pre-travel health seeking behaviour and adherence to pre-travel health advice: a systematic review[J]. J Travel Med, 2019, 26(6): taz059. DOI: 10.1093/jtm/taz059.
[7]	张际文, Steffen R. 构建有中国特色的国际旅行健康服务体系[J]. 中国国境卫生检疫杂志,2017,40(5):305–309,322. DOI:10.16408/j.1004−9770.2017.05.001. Zhang JW, Steffen R. Development and characteristics of travel medicine in China[J]. Chin J Front Health Quar, 2017, 40(5): 305–309,322. DOI: 10.16408/j.1004−9770.2017.05.001.
[8]	胡婷, 肖利力, 张奕. 新时代国际旅行健康信息服务发展的思考与建议[J]. 中国国境卫生检疫杂志,2021,44(6):400–403. DOI:10.16408/j.1004−9770.2021.06.006. Hu T, Xiao LL, Zhang Y. Thinking and suggestions on the development of international travel health information service in the new era[J]. Chin J Front Health Quar, 2021, 44(6): 400–403. DOI: 10.16408/j.1004−9770.2021.06.006.
[9]	Cegolon L, Heymann WC, Lange JH, et al. Travel health education[J]. J Travel Med, 2017, 24(5): tax039. DOI: 10.1093/jtm/tax039.
[10]	Aw B, Boraston S, Botten D, et al. Travel medicine: what's involved? When to refer?[J]. Can Fam Physician, 2014, 60(12): 1091–1103.
[11]	Noble LM, Willcox A, Behrens RH. Travel clinic consultation and risk assessment[J]. Infect Dis Clin North Am, 2012, 26(3): 575–593. DOI: 10.1016/j.idc.2012.05.007.
[12]	Hill DR, Rosselot G. 3-Starting, organizing, and marketing a travel clinic[M]//Keystone JS, Kozarsky RE, Connor BA, et al. Travel Medicine. 4^th ed. London: Elsevier, 2019: 15−24. DOI: 10.1016/B978-0-323-54696-6.00003-3
[13]	Mutie MK. A collaborative role of pharmacists in travel health[D]. Canberra: University of Canberra, 2017.
[14]	Hill DR, Ericsson CD, Pearson RD, et al. The practice of travel medicine: guidelines by the infectious Diseases Society of America[J]. Clin Infect Dis, 2006, 43(12): 1499–1539. DOI: 10.1086/508782.
[15]	ISTM (International Society of Travel medicine). The ISTM body of knowledge for the practice of travel medicine[EB/OL]. (2017-07-01) [2022-08-13]. https://www.istm.org/bodyofknowledge2.
[16]	WC Frederick, K Davis, JE Post. Business and society: Corporate strategy, public policy, ethics[M]. McGraw-Hill Companies, 1998.150−164.
[17]	Rack J, Wichmann O, Kamara B, et al. Risk and spectrum of diseases in travelers to popular tourist destinations[J]. J Travel Med, 2005, 12(5): 248–253. DOI: 10.2310/7060.2005.12502.
[18]	Vilkman K, Pakkanen SH, Lääveri T, et al. Travelers' health problems and behavior: prospective study with post-travel follow-up[J]. BMC Infect Dis, 2016, 16: 328. DOI: 10.1186/s12879−016−1682−0.
[19]	Yu VL, Madoff LC. ProMED-mail: an early warning system for emerging diseases[J]. Clin Infect Dis, 2004, 39(2): 227–232. DOI: 10.1086/422003.
[20]	Eysenbach G. Infodemiology: the epidemiology of (mis) information[J]. Am J Med, 2002, 113(9): 763–765. DOI: 10.1016/s0002−9343(02)01473−0.
[21]	张立宪. 读库2001[M]. 北京: 新星出版社, 2020: 1−38. Zhang LX. Duku 2001[M]. Beijing: New Star Press, 2020: 1−38.